Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura
British Journal of Haematology · 2023-07 · 202 (2) · 429-433
DOI: 10.1111/bjh.18854 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 14.05.2023. Verfasst von Asha Aggarwal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Hauptthemen laut MEDLINE: Purpura, Thrombotic Thrombocytopenic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
- Department of Clinical Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
ORCID-Profile: Asha Aggarwal, Sue Pavord, Will Thomas, Michael J R Desborough
Zitieren
APA
Aggarwal, A., White, D., Pavord, S., Thomas, W., & Desborough, M. J. R. (2023). Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura. British Journal of Haematology, 202(2), 429-433. https://doi.org/10.1111/bjh.18854
Vancouver
Aggarwal A, White D, Pavord S, Thomas W, Desborough MJR. Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura. British Journal of Haematology. 2023;202(2):429-433. doi:10.1111/bjh.18854
BibTeX
@article{Aggarwal2023,
author = {Aggarwal, Asha and White, Danielle and Pavord, Sue and Thomas, Will and Desborough, Michael J R},
title = {Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura},
journal = {British Journal of Haematology},
year = {2023},
volume = {202},
number = {2},
pages = {429--433},
doi = {10.1111/bjh.18854}
}
EUVIMED